Turk J Hematol. 2000; 17(2): 77-79

An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia Minor

Harika Çelebi¹, Celalettin Üstün¹, Mutlu Arat¹, Hamdi Akan¹, Gürol Tunçman², Tayfun Özçelik², Tayfun Özçelik², H. Şenol Coşkun¹, Haluk Koç^1
1Department Of Hematology And Bone Marrow Transplant Unit, Ibn-i Sina Hospital, Ankara University, Ankara, Turkey
²Department Of Molecular Biology, Bilkent University, Ankara, Turkey

b thalassemia minor is frequent in mediterranean countries. It is a benign disorder and does not warrant any therapeutical intervention. We transplanted a 25-year-old Turkish male who was diagnosed as lymphoblastic lymphoma and had b thalassemia minor as well. He received peripheral blood stem cells transplantation from his HLA-identical sibling who was not a carrier of b thalassemia. After the allogeneic transplantation we did not only observe remission of the lymphoblastic lymphoma but also the disappearance of b thalassemia minor.

Keywords: b thalassemia minor, allogeneic peripheral blood stem cell transplantation, lymphoblastic lymphoma

---

CITE